Shaanxi Meibang Pharmaceutical Group Co., Ltd. (605033.SS)
CNY 12.67
(-0.63%)
CNY 12.67
(-0.63%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 699.02 Million | 906.04 Million | 842.49 Million | 568.51 Million | 515.7 Million | 438.55 Million |
| Cost of Revenue | 478.03 Million | 518.85 Million | 520.06 Million | 361.86 Million | 314.16 Million | 274.34 Million |
| Gross Profit | 220.98 Million | 387.19 Million | 322.42 Million | 206.65 Million | 201.54 Million | 164.21 Million |
| Operating Expenses | 179.16 Million | 236.66 Million | 183.4 Million | 115.1 Million | 102.5 Million | 83.23 Million |
| Selling, General and Administrative Expenses | 94.7 Million | 130.57 Million | 99.85 Million | 50.7 Million | 50.91 Million | 45.29 Million |
| Research and Development Expenses | 58.53 Million | 80.04 Million | 63.8 Million | 51.36 Million | 39.51 Million | 26.93 Million |
| Other Expenses | 12.04 Million | 26.05 Million | 19.74 Million | 13.03 Million | 12.07 Million | 554.06 Thousand |
| Cost and Expenses | 648.65 Million | 755.52 Million | 703.46 Million | 476.96 Million | 416.67 Million | 357.57 Million |
| Operating Income | 50.36 Million | 140.27 Million | 122.5 Million | 87.59 Million | 86.04 Million | 66.86 Million |
| Interest Expense | 506.87 Thousand | 979.48 Thousand | 3.3 Million | 852.76 Thousand | 2.98 Million | 4.36 Million |
| Income Tax Expense | 4.85 Million | 7.27 Million | 13.08 Million | 10.65 Million | 9.24 Million | 8.08 Million |
| Earnings before Tax | 62.41 Million | 152.36 Million | 138.83 Million | 89.38 Million | 85.5 Million | 67.41 Million |
| Net Income | 57.55 Million | 145.08 Million | 125.74 Million | 78.73 Million | 76.25 Million | 59.33 Million |
| Earnings Per Share Basic | 0.43 | 1.07 | 0.93 | 0.58 | 0.56 | 0.63 |
| Earnings Per Share Diluted | 0.43 | 1.07 | 0.93 | 0.58 | 0.56 | 0.63 |
| Weighted Average Shares Outstanding | 133.85 Million | 135.2 Million | 135.2 Million | 135.2 Million | 135.2 Million | 94.17 Million |
| Weighted Average Shares Outstanding (Diluted) | 133.85 Million | 135.2 Million | 135.2 Million | 135.2 Million | 135.2 Million | 94.17 Million |
| Gross Margin | 0.32 | 0.43 | 0.38 | 0.36 | 0.39 | 0.37 |
| EBIT Margin | 0.12 | 0.20 | 0.20 | 0.18 | 0.20 | 0.19 |
| Profit Margin | 0.08 | 0.16 | 0.15 | 0.14 | 0.15 | 0.14 |
| EBITDA | 84.13 Million | 150.04 Million | 154.61 Million | 100.89 Million | 97.79 Million | 79.92 Million |
| Earnings Before Tax Margin | 0.07 | 0.15 | 0.15 | 0.15 | 0.17 | 0.15 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 111.92 Million | 195.97 Million | 312.08 Million | 145.39 Million | 699.02 Million | 77.48 Million |
| Cost of Revenue | 76.27 Million | 145.15 Million | 212.89 Million | 105.36 Million | 459.92 Million | 58.38 Million |
| Gross Profit | 35.65 Million | 50.82 Million | 99.19 Million | 40.02 Million | 239.09 Million | 19.1 Million |
| Operating Expenses | 37.06 Million | 57.6 Million | 44.18 Million | 63.31 Million | 179.16 Million | 29.13 Million |
| Selling, General and Administrative Expenses | 19.99 Million | 35.84 Million | 32.26 Million | 13.89 Million | - | 36.72 Million |
| Research and Development Expenses | 16.41 Million | 17.6 Million | 17.03 Million | 25.15 Million | - | 4.28 Million |
| Other Expenses | -17.06 Million | -4.15 Million | 22.63 Thousand | 10.03 Million | 12.04 Million | 422.29 Thousand |
| Cost and Expenses | 113.33 Million | 202.75 Million | 257.07 Million | 168.67 Million | 639.08 Million | 87.51 Million |
| Operating Income | -1.4 Million | -6.77 Million | 49.55 Million | -33.88 Million | 50.36 Million | -2.77 Million |
| Interest Expense | - | 1145.83 | 8333.35 | 10.62 Thousand | 375.41 Thousand | 9583.34 |
| Income Tax Expense | 5.22 Million | -2.38 Million | 5.13 Million | -11.21 Million | 4.85 Million | 1.07 Million |
| Earnings before Tax | 1.07 Million | 606.87 Thousand | 49.57 Million | -23.84 Million | 62.41 Million | -2.34 Million |
| Net Income | -4.15 Million | 2.98 Million | 44.43 Million | -12.63 Million | 57.55 Million | -3.41 Million |
| Earnings Per Share Basic | -0.03 | 0.02 | 0.33 | -0.10 | - | -0.03 |
| Earnings Per Share Diluted | -0.03 | 0.02 | 0.33 | -0.10 | - | -0.03 |
| Weighted Average Shares Outstanding | 135.2 Million | 135.2 Million | 134.66 Million | 131.38 Million | 133.85 Million | 135.2 Million |
| Weighted Average Shares Outstanding (Diluted) | 135.2 Million | 135.2 Million | 134.66 Million | 131.38 Million | 133.85 Million | 135.2 Million |
| Gross Margin | 0.32 | 0.26 | 0.32 | 0.28 | 0.34 | 0.25 |
| EBIT Margin | 0.01 | -0.01 | 0.18 | -0.07 | - | -0.11 |
| Profit Margin | -0.04 | 0.02 | 0.14 | -0.09 | 0.08 | -0.04 |
| EBITDA | 1.07 Million | -1.25 Million | 56.68 Million | -10.78 Million | - | -8.7 Million |
| Earnings Before Tax Margin | -0.01 | -0.03 | 0.16 | -0.23 | 0.07 | -0.04 |
AUSTENG
RBT
8984
KARMAENG
ELAND
CCAJ